Conference Description

May 5, 2007
Sheraton Clayton Plaza Hotel
7730 Bonhomme Avenue
St. Louis, MO 63105
314-863-0400

Tell a friend about this conference

Download the brochure for this conference

See how attendees evaluated this conference

CME Credits: 8*

Nonrefundable registration fee: $0.

Target Audience: Physicians, Nurse Practitioners, and Physician Assistants.

Program Summary:

This program will provide Primary Care Physicians the opportunity to learn first hand from national thought leaders in their field. The goal is to provide a clearer understanding of several of the most common disease processes, in light of rapid scientific advances. By doing so, attendees will walk away with new insights and learn useful strategies to manage the challenges faced on a daily basis. This program will incorporate didactic lectures, case based learning, and utilize an audience response system to facilitate discussion among participants to enhance the educational opportunity.

Learning Objectives:
At the conclusion of this program, participants should be able to:

1. appreciate that given its favorable risk to benefit ratio, the more widespread and appropriate aggressive management of patients with statins will confer statistically significant and clinically important reductions in myocardial infarction, stroke, and deaths from cardiovascular disease
2. understand the role of immune response modifiers in optimizing control of keloids and post-surgical scars; appreciate the mechanisms of action and efficacy of anti-inflammatory dose doxycycline in acne rosacea, and become knowledgeable regarding the controversy regardng the role of diet in acne vulgaris.
3. review early pathogenesis and prevention of type 2 diabetes, more effectively attain tight glucose control and discuss recent outcomes trials on the development and progression of atherosclerosis in diabetes
4. review glycemic and cardiovascular outcomes from insulin trials in type 2 diabetes, and optimize glycemic control with insulin in type 2 diabetes while minimizing weight gain and hypoglycemia
5. critically evaluate the evidence behind diagnostic and therapeutic options for constipation predominant irritable bowel syndrome and chronic constipation
6. appreciate recent advances in our understanding of the neurobiology of sleep-wake regulation, and understand behavioral and pharmacological approaches to insomnia including their application in the clinical setting
7. utilize diagnostic criteria for Restless Leg Syndrome, understand recent advances in the pathophysiology of the disease, utilize current behavioral and pharmacologic treatment options to reduce symptoms and increase quality of life
8. understand the etiology of Male LUTS (including BPH, overactive bladder, and smooth muscle dysfunction) and the types of medical and surgical therapies available as well as the rationale behind their use in order to make better therapeutic decisions in clinical practice
9. understand the ramifications of the Women’s Health Intitiative Study of 2002 and how it is still affecting the way practitioners treat menopause, especially in light of breast and uterine cancer and cardiovascular disease. Participants will know how to select the appropriate patient for hormone replacement therapy and choose between different options available.

Agenda:
Saturday, May 5, 2007

7:15-7:50 am		Registration, Continental Breakfast and Welcome
7:50-8:10		Welcome Remarks and Pre-Assessment Gregg Sherman, MD
8:10-9:00		Update on Statins in the Treatment and Prevention of Cardiovascular Disease: Clinical and Public Health Challenges Charles Hennekens, MD
9:00-9:50		Dermatology Therapy Update — Scars, Acne Rosacea & Acne Brian Berman, MD
9:50-10:10		Break
10:10-11:00		Fundamentals of Quality Diabetes Care Patrick J. Boyle, MD
11:00-11:50		Insulin Therapy in Type 2 Diabetes— Who, When, and How — Patrick J. Boyle, MD
11:50-12:40		Evolving Concepts in GI Motility Disorders: IBS-Constipation and Chronic Constipation Kenneth R. DeVault, MD
12:40-1:30		Lunch
1:30-2:20		Managing insomnia in 2007 Gary Richardson, MD
2:20-3:10		Restless Leg Syndrome: Diagnosis and Management Gary Richardson, MD
3:10-3:30		Break
3:30-4:20		Meeting the Challenge of Male Lower Urinary Tract Symptoms: It’s not just BPH anymore Ross Rames, MD
4:20-5:10		Hormone Replacement Therapy in 2007: Where Do We Stand? Tara Solomon, MD
5:10-5:20		Conference Wrap Up and Post Assessment

Faculty:
Brian Berman, MD, PhD
Professor of Dermatology and Internal Medicine
The University of Miami School of Medicine, Miami, FL

Patrick J. Boyle, MD
Professor of Medicine
University of New Mexico
Albuquerque, NM

Kenneth R. DeVault, MD
Professor of Medicine
Chair, Division of Gastroenterology and Hepatology
Mayo Clinic College of Medicine
Jacksonville, FL

Charles Hennekens, MD
Co-Director of Cardiovascular Research at MSMC-MHI
Professor of Medicine & Epidemiology and Public Health
University of Miami School of Medicine
Miami, FL

Ross Rames, MD
Associate Professor of Urology
Division of Urodynamics and Continence
Medical University of South Carolina
Charleston, SC

Gary S. Richardson, MD
Senior Research Scientist
Sleep Research and Disorders Center
Henry Ford Hospital
Detroit, MI

Tara Solomon, MD
Medical Director
The Women’s Wellness Center of South Florida
Margate, FL

Program Chair: Gregg Sherman, MD

Activity Director: Michelle Frisch, MPH

*Continuing Education Information
This activity has been reviewed and is acceptable for up to 8.0 Prescribed credit(s) by the American Academy of Family Physicians. The AAFP invites comments on any activity that has been approved for AAFP CME credit. Please forward your comments on the quality of this activity to cmecomment@aafp.org.

This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Massachusetts Medical School (UMMS) and the National Association for Continuing Education. The University of Massachusetts Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Massachusetts Medical School designates this educational activity for a maximum of 7.5 AMA PRA Category I Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Under the auspices of the University of Massachusetts Medical School Office of Continuing Education this offering meets the requirements for 9 contact hours, as specified by the Massachusetts Board of Registration in Nursing (244- CMR 5.04). Each nurse should claim only those hours of credit that he/she actually spent in the educational activity.

Policy on Faculty and Provider Disclosure: It is the policy of the University of Massachusetts Medical School to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the University of Massachusetts Medical School are required to present evidenced- based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.

This program was supported through educational grants from the following companies: Amylin, AstraZeneca, Boehringer Ingelheim, Collagenex, Merck, Novo nordisk, sanofi-aventis, Takeda, Wyeth.